Literature DB >> 14645133

Thioredoxin: a key regulator of cardiovascular homeostasis.

Hideyuki Yamawaki1, Judith Haendeler, Bradford C Berk.   

Abstract

The thioredoxin (TRX) system (TRX, TRX reductase, and NADPH) is a ubiquitous thiol oxidoreductase system that regulates cellular reduction/oxidation (redox) status. The oxidation mechanism for disease pathogenesis states that an imbalance in cell redox state alters function of multiple cell pathways. In this study, we review the essential role for TRX to limit oxidative stress directly via antioxidant effects and indirectly by protein-protein interaction with key signaling molecules, such as apoptosis signal-regulating kinase 1. We propose that TRX and its endogenous regulators are important future targets to develop clinical therapies for cardiovascular disorders associated with oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645133     DOI: 10.1161/01.RES.0000102869.39150.23

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  57 in total

1.  Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.

Authors:  Ram Sudheer Adluri; Mahesh Thirunavukkarasu; Lijun Zhan; Yuzo Akita; Samson Mathews Samuel; Hajime Otani; Ye-Shih Ho; Gautam Maulik; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2010-11-11       Impact factor: 5.000

2.  Regulation of MyD88-dependent signaling events by S nitrosylation retards toll-like receptor signal transduction and initiation of acute-phase immune responses.

Authors:  Takeshi Into; Megumi Inomata; Misako Nakashima; Ken-Ichiro Shibata; Hans Häcker; Kenji Matsushita
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

Review 3.  Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms.

Authors:  Thomas E Gunter; Shey-Shing Sheu
Journal:  Biochim Biophys Acta       Date:  2009-01-06

4.  Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.

Authors:  Cemile Jakupoglu; Gerhard K H Przemeck; Manuela Schneider; Stéphanie G Moreno; Nadja Mayr; Antonis K Hatzopoulos; Martin Hrabé de Angelis; Wolfgang Wurst; Georg W Bornkamm; Markus Brielmeier; Marcus Conrad
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Neuroprotective effect of recombinant adeno-associated virus human thioredoxin-PR39 on acute cerebral infarction in rats.

Authors:  Yu-Dong Guo; Teng Huang; Wen-Hua Sheng; Yun-Fei Guan; Yi-Feng Du; You-Ting Lin; Xi-Yun Ruan
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

6.  Oxidoreductase regulation of Kv currents in rat ventricle.

Authors:  Huixu Liang; Xun Li; Shumin Li; Ming-Qi Zheng; George J Rozanski
Journal:  J Mol Cell Cardiol       Date:  2008-03-28       Impact factor: 5.000

7.  Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion.

Authors:  Young-Mi Go; Patrick J Halvey; Jason M Hansen; Matt Reed; Jan Pohl; Dean P Jones
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

Review 8.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

Review 9.  Redox regulation of sodium and calcium handling.

Authors:  Stefan Wagner; Adam G Rokita; Mark E Anderson; Lars S Maier
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

10.  Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions.

Authors:  Shaker A Mousa; Christine Gallati; Tessa Simone; Emmy Dier; Murat Yalcin; Evgeny Dyskin; Sudha Thangirala; Christine Hanko; Abdelhadi Rebbaa
Journal:  Aging (Albany NY)       Date:  2009-03-31       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.